Moderna, Inc.
Current role
MRNA
David Rubenstein
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David Rubenstein
Moderna, Inc. reported in an 8-K filed July 8, 2026 that David Rubenstein was appointed member of the Nominating and Corporate Governance Committee.
“Simultaneously with Mr. McDonnell's appointment to serve on the Audit Committee, David Rubenstein ceased to serve as a member of the Audit Committee and was appointed to serve on the Nominating and Corporate Governance Committee.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Moderna, Inc. (MRNA)
SEC 8-K
Current2026-07-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Moderna, Inc.
Other people whose current roles at this company are on record from its filings.
- Stéphane Bancel CEO, Board Member
- Noubar Afeyan Chairman, Board Member
- David W. Meline CFO
- James Mock CFO
- Jorge M. Gomez CFO
- Lorence Kim CFO
- Juan Andres COO
- Dr. Jerh Collins CTO
- Lori Henderson General Counsel
- Abbas Hussain Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.